臨床試験用品の市場規模、シェア、成長分析、フェーズ別、製品とサービス別、最終用途別、治療法別、地域別 - 産業予測 2025年～2032年

臨床試験用品市場規模は2023年に31億米ドルと評価され、2024年の33億1,000万米ドルから2032年には56億5,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは6.9％で成長する見通しです。

世界の臨床試験用品市場は、バイオ医薬品・製薬分野における研究開発費の増加、臨床試験の増加、新興国における医薬品開発費の高騰などを背景に大きな成長を遂げています。しかし、この成長は、薬剤研究に関連する高コストやCOVID-19パンデミックの長引く影響による課題に直面しています。慢性疾患の世界の蔓延は、この分野の需要をさらに押し上げています。さらに、受託製造業者やサービスプロバイダーはアウトソーシングソリューションを提供する上で極めて重要であり、製薬会社は医薬品の製剤を改良し、同業他社との連携を強化することができます。フィッシャー・クリニカル・サービスやパレクセル・インターナショナルなど、確立されたロジスティクスと流通のパートナーシップも市場開発を後押しし、臨床試験用品を現代的な医薬品開発の要として位置づけています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 規制分析

臨床試験用品市場規模：フェーズ別& CAGR（2025-2032）

• 市場概要
• フェーズI
• フェーズII
• フェーズIII
• その他

臨床試験用品市場規模：製品とサービス別& CAGR（2025-2032）

• 市場概要
• 製造業
• 保管と配送
• サプライチェーンマネジメント

臨床試験用品市場規模：最終用途別& CAGR（2025-2032）

• 市場概要
• 医薬品
• 生物学的製剤
• 医療機器
• その他

臨床試験用品市場規模：治療法別 & CAGR（2025-2032）

• 市場概要
• 腫瘍学
• 中枢神経系
• 心血管系
• 感染症
• 代謝障害
• その他

臨床試験用品市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024年）

主要企業プロファイル

• Almac Group（UK）
• Thermo Fisher Scientific Inc.（USA）
• Marken（UPS）（USA）
• PCI Pharma Services（USA）
• Sharp Services LLC（USA）
• Cencora, Inc.（USA）
• Myonex（USA）
• Clinigen Limited（UK）
• Inceptua Group（Luxembourg）
• Eurofins Scientific（Luxembourg）
• IQVIA（USA）
• Parexel International Corporation（USA）
• ICON plc（Ireland）
• Catalent, Inc.（USA）
• Piramal Pharma Solutions（India）
• Biocair（UK）
• Lonza（Switzerland）
• World Courier（USA）
• Klifo A/S（Denmark）
• DHL Supply Chain（Germany）

結論と提言

Clinical Trial Supplies Market size was valued at USD 3.1 billion in 2023 and is poised to grow from USD 3.31 billion in 2024 to USD 5.65 billion by 2032, growing at a CAGR of 6.9% during the forecast period (2025-2032).

The global clinical trial supplies market is witnessing significant growth driven by rising R&D expenditures within biopharmaceutical and pharmaceutical sectors, an increase in clinical trials, and escalating drug development costs in developed nations. However, this growth faces challenges due to the high costs associated with drug research and the lingering effects of the COVID-19 pandemic. The increasing prevalence of chronic illnesses worldwide further fuels demand in this sector. Moreover, contract manufacturers and service providers are crucial in offering outsourcing solutions, allowing pharmaceutical companies to refine drug formulations and enhance collaboration with peers. Established logistics and distribution partnerships, such as with Fisher Clinical Services and PAREXEL International, are also boosting market expansion, positioning clinical trial supplies as a cornerstone of modern drug development.

Top-down and bottom-up approaches were used to estimate and validate the size of the Clinical Trial Supplies market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Clinical Trial Supplies Market Segments Analysis

Global Clinical Trial Supplies Market is segmented by Phase, Products and Services, End Use, Therapeutic and region. Based on Phase, the market is segmented into Phase I, Phase II, Phase III and Others. Based on Products and Services, the market is segmented into Manufacturing, Storage and Distribution and Supply Chain Management. Based on End Use, the market is segmented into Pharmaceutical, Biologics, Medical device and Others. Based on Therapeutic, the market is segmented intooncology, CNS, Cardiovascular, Infectious disease, Metabolic disorders and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Clinical Trial Supplies Market

A significant driver of the global clinical trial supplies market is the growing emphasis on precision medicine. As therapies become more tailored to individual patients, there is an escalating demand for innovative treatment solutions and biologic medications. This shift necessitates the development of specialized clinical trial supplies to effectively manage the complexities associated with advanced clinical trial designs and the stratification of patients. Consequently, the evolution of precision medicine is propelling the need for refined and targeted clinical trial resources, ultimately shaping the landscape of clinical trials to better meet the diverse needs of patients and researchers alike.

Restraints in the Clinical Trial Supplies Market

The global clinical trial supplies market faces significant challenges due to disruptions in the global supply chain. Factors such as political conflicts, natural disasters, and health crises can severely impact the availability of essential materials and transportation logistics. These disruptions can lead to delays in the initiation of clinical trials and result in increased operational expenses, ultimately diminishing the overall efficiency of clinical research activities. The unpredictable nature of these events poses a substantial restraint, hindering progress and complicating the management of clinical trial supplies on a global scale.

Market Trends of the Clinical Trial Supplies Market

The Clinical Trial Supplies market is experiencing a significant shift towards decentralized clinical trials, driven by technological advancements and the growing acceptance of virtual study methodologies. This trend is enabling remote patient monitoring and broadening participant access, resulting in reduced operational costs and expedited trial timelines. By facilitating greater inclusivity and efficiency, decentralized trials are transforming traditional clinical research models, allowing for more dynamic patient engagement and data collection. As a result, pharmaceutical companies and CROs are increasingly investing in innovative supply chain solutions to adapt to these changes, positioning the market for continued growth and evolution through enhanced logistics and tailored supply strategies.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis

Global Clinical Trial Supplies Market Size by Phase & CAGR (2025-2032)

• Market Overview
• Phase I
• Phase II
• Phase III
• Others

Global Clinical Trial Supplies Market Size by Products and Services & CAGR (2025-2032)

• Market Overview
• Manufacturing
• Storage and Distribution
• Supply Chain Management

Global Clinical Trial Supplies Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Pharmaceutical
• Biologics
• Medical device
• Others

Global Clinical Trial Supplies Market Size by Therapeutic & CAGR (2025-2032)

• Market Overview
• Oncology
• CNS
• Cardiovascular
• Infectious disease
• Metabolic disorders
• Others

Global Clinical Trial Supplies Market Size & CAGR (2025-2032)

• North America (Phase, Products and Services, End Use, Therapeutic)
  • US
  • Canada
• Europe (Phase, Products and Services, End Use, Therapeutic)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Phase, Products and Services, End Use, Therapeutic)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Phase, Products and Services, End Use, Therapeutic)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Phase, Products and Services, End Use, Therapeutic)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Almac Group (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Marken (UPS) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PCI Pharma Services (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sharp Services LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cencora, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Myonex (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Clinigen Limited (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inceptua Group (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IQVIA (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Parexel International Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICON plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Catalent, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Piramal Pharma Solutions (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocair (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• World Courier (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Klifo A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DHL Supply Chain (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations